ICICI Securities Ltd | Retail Equity Research Revenues increased 13% YoY to | 1852 crore (I-direct estimate: | 1835 crore) led by 11% YoY increase in healthcare business to | 1024 crore (I-direct estimate: | 1002 crore) and 17% YoY increase in pharmacy business to | 828 crore (I-direct estimate: | 794 crore) EBITDA margins declined 163 bps YoY to 11.9% (I-direct estimate: 12.1%) mainly due to higher employee and other expenditure. EBITDA remained flat YoY at | 221 crore...